Insider Trading & Ownership of Gwen A. Melincoff

Location: Carmiel
Summary: The estimated net worth of Gwen A. Melincoff is at least $1.82M dollars as of 04 Sep 2025. Gwen A. Melincoff is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.69M. Gwen A. Melincoff is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $87.9K. Gwen A. Melincoff is the Director of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $24.3K. Gwen A. Melincoff is the Director of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $11.6K.
Signature: /s/ Joseph R. Magnas, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Gwen A. Melincoff files a new Insider Trading report.

Ownership of Gwen A. Melincoff

Symbol	Company	Relationship	Holdings Value	Report Period
COLL	COLLEGIUM PHARMACEUTICAL, INC	Director	$1.69M	16 May 2024
GANX	Gain Therapeutics, Inc.	Director	$87.9K	24 Jun 2025
SLNO	SOLENO THERAPEUTICS INC	Director	$24.3K	25 May 2023
PLX	Protalix BioTherapeutics, Inc.	Director	$11.6K	03 Sep 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.